Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001199835-22-000824
Filing Date
2022-12-19
Accepted
2022-12-19 16:20:43
Documents
36
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 PEAK PHARMACEUTICALS, INC. 12/31/2020 10-Q pkph123120-10q.htm 10-Q 255479
2 CERTIFICATION pkph123120-ex31_1.htm EX-31.1 17996
3 CERTIFICATION pkph123120-ex31_2.htm EX-31.2 18096
4 CERTIFICATION pkph123120-ex32_1.htm EX-32.1 7291
5 CERTIFICATION pkph123120-ex32_2.htm EX-32.2 7320
  Complete submission text file 0001199835-22-000824.txt   1242578

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pkph-20201231.xml EX-101.INS 119047
7 XBRL SCHEMA FILE pkph-20201231.xsd EX-101.SCH 17274
8 XBRL CALCULATION FILE pkph-20201231_cal.xml EX-101.CAL 17878
9 XBRL DEFINITION FILE pkph-20201231_def.xml EX-101.DEF 34966
10 XBRL LABEL FILE pkph-20201231_lab.xml EX-101.LAB 120438
11 XBRL PRESENTATION FILE pkph-20201231_pre.xml EX-101.PRE 95796
Mailing Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260
Business Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260 480.659.6404
PEAK PHARMACEUTICALS, INC. (Filer) CIK: 0001452804 (see all company filings)

EIN.: 261973257 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-53855 | Film No.: 221471349
SIC: 2834 Pharmaceutical Preparations